Search for: "Masters v. State"
Results 101 - 120
of 3,904
Sort by Relevance
|
Sort by Date
5 Oct 2023, 5:35 am
Lutz v. [read post]
5 Oct 2023, 4:59 am
His decision on circuit in United States v. [read post]
4 Oct 2023, 6:30 am
Resisting criticism, that Chief Justice declared himself the undisputed ‘master of the roster’, and recent accounts show that Chief Justices continue to use this power strategically in assigning cases. [read post]
3 Oct 2023, 10:21 am
Further reading: Arthrex, Inc. v. [read post]
3 Oct 2023, 9:57 am
Or is this concept state-centric? [read post]
2 Oct 2023, 1:51 am
Her appointment was described by the Master of the Rolls as “a landmark in our national life”. [read post]
1 Oct 2023, 6:30 am
In the recent UK Supreme Court decision O (a minor), R (on the application of v Secretary of State for the Home Department [2022] UKSC 3, Lord Hodge provided a pithy statement of the approach of the courts in that jurisdiction. [read post]
30 Sep 2023, 1:40 am
Art Law cases handled as an Assistant United States Attorney: United States v. [read post]
28 Sep 2023, 5:03 am
See the decision in New York v Trump, Et Al here. [read post]
26 Sep 2023, 12:27 pm
The case Milligan v. [read post]
22 Sep 2023, 8:57 am
Tsakopoulos Investments, LLC v. [read post]
20 Sep 2023, 9:24 am
One of the earliest examples is Hahn v. [read post]
20 Sep 2023, 6:24 am
’ The case is Jones v. [read post]
19 Sep 2023, 2:24 pm
One of the earliest examples is Hahn v. [read post]
16 Sep 2023, 6:44 am
Hamaday v. [read post]
14 Sep 2023, 6:51 am
It is directed instead to oppositional forces within those states and, more importantly, to the larger group of post-colonial and developing states that are always attentive to changes that might advantage them in their relationship with their former colonial masters or the orthodox hegemony (the terms of the relationship of which always appear ripe for renegotiation). [read post]
12 Sep 2023, 12:06 pm
” Allen v. [read post]
10 Sep 2023, 7:24 pm
The final guidance contains a new addition that states that if there is an appropriate justification as to why a sponsor cannot submit patient-level data to FDA through traditional channels, third parties can provide these data through either a pre-IND or Type V Drug Master File (“DMF”) and provide the sponsor with a letter of authorization for FDA to reference the data. [read post]
8 Sep 2023, 10:31 am
Maropakis Carpentry, Inc. v. [read post]
5 Sep 2023, 2:29 pm
The case, Allen v. [read post]